Home 2023

Antiviral agents

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar
GEN Edge

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar

Alex Philippidis -
0
SARS-CoV-2 Mutation Signature Linked to Antiviral Molnupiravir
Infectious Diseases

SARS-CoV-2 Mutation Signature Linked to Antiviral Molnupiravir

Julianna LeMieux, PhD -
0
Poxvirus Therapy: Existing Drugs May Offer New, More Durable Approach
Featured

Poxvirus Therapy: Existing Drugs May Offer New, More Durable Approach

Sophia Ktori -
0
Antiviral Peptoids Target Lipid to Burst Bubble-Like Membranes
Infectious Diseases

Antiviral Peptoids Target Lipid to Burst Bubble-Like Membranes

Sophia Ktori -
0
HIV-Drug Binding Structures Point to Resistance Mechanisms
Featured

HIV-Drug Binding Structures Point to Resistance Mechanisms

Sophia Ktori -
0
Cryo-EM Research May Help Develop Antiviral Therapy against HIV
Infectious Diseases

Cryo-EM Research May Help Develop Antiviral Therapy against HIV

Christina Jackson -
0
AGT Spins Out Addimmune, Focusing on Functional HIV Cure
Drug Discovery

AGT Spins Out Addimmune, Focusing on Functional HIV Cure

Alex Philippidis -
0
HIV Hides Out In Brain-Resident Immune Cells
Featured

HIV Hides Out In Brain-Resident Immune Cells

Sophia Ktori -
0
Dual CRISPR Gene Editing Strategy Cures Animals of HIV-1
Featured

Dual CRISPR Gene Editing Strategy Cures Animals of HIV-1

Sophia Ktori -
0
Dementia-Related Proteins Protected by HIV Drug in Mice
Drug Discovery

Dementia-Related Proteins Protected by HIV Drug in Mice

Christina Jackson -
0
123...12Page 1 of 12
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.